Yes, refer this 33-year-old patient to urology for cystoscopy evaluation
Despite the normal CT urogram, this patient with 11-30 RBCs/HPF meets criteria for urologic evaluation and should be referred to urology for cystoscopy. The imaging has only evaluated the upper urinary tract; the lower urinary tract (bladder and urethra) requires direct visualization to exclude urothelial malignancy, which cannot be adequately assessed by CT alone.
Risk Stratification and Rationale
According to the 2025 AUA/SUFU guidelines, this patient falls into the intermediate-risk category based on:
- 11-25 RBC/HPF on urinalysis (meets intermediate-risk threshold) 1
- Age 33 years (below the high-risk age cutoff but warrants evaluation)
The 2020 ACR Appropriateness Criteria emphasize that many patients with microhematuria should undergo cystoscopy in addition to any imaging evaluation 2. The CT urogram has addressed the upper tract, but cystoscopy remains necessary to complete the evaluation.
Why Cystoscopy is Still Needed
CT urography alone is insufficient for complete hematuria evaluation. While your CT urogram has effectively ruled out:
- Renal masses
- Urothelial tumors of the renal pelvis and ureters
- Urolithiasis
- Hydronephrosis
It cannot adequately visualize:
- Bladder urothelial carcinoma (including carcinoma in situ)
- Bladder masses or polyps
- Urethral pathology
The complete urologic evaluation requires both upper tract imaging (completed) and lower tract visualization via cystoscopy 3. Even in younger patients, the risk of malignancy with this degree of hematuria (2.6-4% overall for microhematuria) justifies direct bladder examination 2.
Clinical Decision Algorithm
For this specific patient:
- ✓ Upper tract imaging completed (normal CT urogram)
- → Next step: Urology referral for cystoscopy
- → Consider urine cytology if additional risk factors present (smoking >10 pack-years, occupational exposures, irritative voiding symptoms) 1
Important Risk Factors to Assess Before Referral
Document the following to help the urologist with risk stratification 1:
- Smoking history (pack-years calculation)
- Occupational exposures (chemicals, dyes, benzenes, aromatic amines)
- History of gross hematuria (even if resolved)
- Irritative voiding symptoms
- History of pelvic irradiation
- Chronic UTIs or indwelling catheters
- Family history of urologic malignancies
Common Pitfalls to Avoid
Do not assume a normal CT urogram completes the evaluation. This is a frequent error that can delay bladder cancer diagnosis. The 2001 AUA guidelines explicitly state that complete urologic evaluation includes "radiologic imaging of the upper urinary tract followed by cystoscopic examination of the urinary bladder" 3.
Do not defer evaluation based on young age alone. While age <40 years (men) or <60 years (women) places patients in lower risk categories, it does not eliminate the need for evaluation when persistent microhematuria is documented 1. The degree of hematuria (11-30 RBCs/HPF) is significant enough to warrant complete workup regardless of age.
Do not repeat urinalysis indefinitely hoping hematuria resolves. With this degree of hematuria and no identified benign cause (infection, menstruation, vigorous exercise, trauma), proceeding with urologic evaluation is appropriate 2.
What the Urologist Will Do
The urology consultation will include:
- Cystoscopy (office-based, typically flexible cystoscopy under local anesthesia)
- Review of upper tract imaging
- Possible urine cytology if not already performed
- Risk-based surveillance recommendations
If cystoscopy is normal and no glomerular disease is suspected (no proteinuria, no dysmorphic RBCs, normal creatinine), the patient may be followed with periodic urinalysis rather than repeated invasive testing 1.
Special Considerations
If there were evidence of glomerular disease (proteinuria >500 mg/24hr, dysmorphic RBCs >80%, red cell casts, elevated creatinine), concurrent nephrology referral would be indicated, but this should not preclude urologic evaluation 2. However, your question specifies no infection and normal imaging, suggesting non-glomerular hematuria.
The malignancy risk with microhematuria ranges from 2.6-4% overall, but this risk is concentrated in those with risk factors 2. Even without traditional high-risk features, the degree of hematuria (11-30 RBCs/HPF) justifies completing the evaluation with cystoscopy to avoid missing treatable bladder pathology.